Cookies?
Library Header Image
LSE Research Online LSE Library Services

Economic analysis of acupuncture for migraine prophylaxis

Pokladnikova, Jitka, Maresova, Petra, Dolejs, Josef, Park, A-La ORCID: 0000-0002-4704-4874, Wang, Bo, Guan, Xin and Musil, Frantisek (2018) Economic analysis of acupuncture for migraine prophylaxis. Neuropsychiatric Disease and Treatment, 14. 3053–3061. ISSN 1178-2021

[img] Text (Economic-analysis-of-acupuncture-for-migraine-prophylaxis) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (562kB)

Identification Number: 10.2147/NDT.S174870

Abstract

BACKGROUND: Acupuncture has become a viable option for migraine prophylaxis in Europe; however, despite its wide use, more data on the short- and long-term cost-effectiveness are needed when considering the perspectives of a paying third-party, the patient, and of society in general. The aim was to evaluate the cost and effectiveness of adjuvant acupuncture to pharmacologic treatment vs pharmacologic treatment alone in migraine patients after a 3-month acupuncture course and a 6-month follow-up from all perspectives. METHODS: The study involved an open-label randomized clinical trial of patients receiving acupuncture (n=42), and a waiting list control group (n=44). The number of migraine days during the last 28 days, as well as direct and indirect costs were considered. The trial was registered under DRKS00009803. RESULTS: The total cost per patient reached €696 vs €285 after 3 months of acupuncture and €66 vs €132 in the acupuncture and control groups after a 6-month follow-up, respectively (P=0.071). The trends observed in effectiveness and costs from all perspectives are discussed. CONCLUSION: The inclusion of acupuncture in health care results beneficial mainly for its observed trend in reduced losses of productivity and income, with the latter often exceeding the costs of acupuncture treatment. As such, acupuncture may be recommended as an adjuvant treatment in migraine prophylaxis to standard pharmacotherapy.

Item Type: Article
Additional Information: © 2018 The Authors
Divisions: Care Policy and Evaluation Centre
Subjects: R Medicine > RZ Other systems of medicine
Date Deposited: 26 Feb 2019 12:15
Last Modified: 14 Sep 2024 07:42
URI: http://eprints.lse.ac.uk/id/eprint/100137

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics